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Abstract
A total of 11 enzymes were assessed including alpha-amylase, endo-1,4-beta-glucanase, endo-1,4-beta-
xylanase and endo-1,3(4)-beta-glucanase as silage additives for all animal species. These enzymes are
obtained by fermentation of bacterial or fungi non-genetically modiﬁed production strains. Throughout
information regarding the production strains of each product were provided, including the origin and
history of modiﬁcations and allowing their identiﬁcation. The identiﬁcation was conclusive for 8 of 10
production strains. For three of the strains, more information/data would still be required in order to
conclude. Three of the amylases are produced by bacterial strains that belong to a species that is
considered by EFSA to be suitable for the Qualiﬁed Presumption of Safety approach to safety
assessment. The identity of the strains has been established and the qualiﬁcations were met, and
consequently, those products were regarded as safe. For the products derived from fungal strains, the
strains or resulting products were tested for the presence of secondary metabolites which could be of
toxicological concern. These were found to be below the limits of detection or the strain not capable of
producing them. Considering all the information provided by the applicant, the Panel concluded that
these products can be regarded as safe for the target species, consumer and the environment. In the
absence of data, the Panel could not conclude on the skin and eye irritancy or skin sensitisation potential
of the products under evaluation. These products should be considered to have the potential to be a
respiratory sensitiser. For some of the products under evaluation, the Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) concluded that they have a potential to improve the
characteristic of the silage material; for some other products, the Panel could not conclude on their
efﬁcacy.
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Summary
Following a request from the European Commission, the Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on Safety and
efﬁcacy of alpha-amylases, cellulases, xylanases and a beta-glucanase from various sources as silage
additives for all animal species.
A total of 11 enzymes were assessed including alpha-amylase (amylase; Enzyme Commission
Number (EC) 3.2.1.1) from Bacillus amyloliquefaciens DSM 9553, B. amyloliquefaciens NCIMB 30251,
Aspergillus oryzae CBS 585.94 and A. oryzae ATTC SD-5374, endo-1,4-beta-glucanase (cellulase; EC
3.2.1.4) from Trichoderma reesei American type culture collection (ATCC) PTA-10001, T. reesei ATCC
SD-6331 and Aspergillus niger CBS 120604, endo-1,4-beta-xylanase (xylanase; EC 3.2.1.8) from
Trichoderma koningii MUCL 39203 and Trichoderma citrinoviride CBS 614.94 and endo-1,3(4)-beta-
glucanase (glucanase; EC 3.2.1.6) from Aspergillus tubingensis MUCL 39199 as silage additives for all
animal species.
Throughout information regarding the production, strains of each product were provided. However,
for the amylase produced with A. oryzae CBS 585.94, the information given was not descriptive
enough to know if the production strain is CBS 585.94 or a derivative of it. Furthermore, the
information regarding the identity of strains T. koningii MUCL 39203 and A. tubingensis MUCL 39199
should be completed in order to evaluate the adequacy of the methods used.
Three of the amylases are produced by bacterial strains that belong to a species (B. amyloliquefaciens)
that is considered by European Food Safety Authority (EFSA) to be suitable for the Qualiﬁed Presumption
of Safety approach to safety assessment. This approach requires the identity of the strain to be
conclusively established and evidence that the strain does not show resistance to antimicrobials relevant
for humans and animals and the absence of toxigenic activity. In the view of the FEEDAP Panel, the
identity of the strains has been established and the qualiﬁcations were met, and consequently, products A,
B and C are regarded as safe. For the products derived from fungal strains, the strains or resulting
products were tested for the presence of secondary metabolites which could be of toxicological concern.
These were found to be below the limits of detection or the strain not capable of producing them.
For the assessment of the safety of the product for the target species, consumer and environment,
the Panel took into consideration (i) the nature of the active substances, (ii) the characteristics of the
production strains and the resulting products (including purity parameters), (iii) the conditions of use
and the intended use in silage and concluded that the enzyme products used as silage may be
regarded as safe for the target species, consumer and the environment. For product D, the conclusion
would apply only in the case that the production strain was A. oryzae CBS 585.94.
In the absence of data, the Panel could not conclude on the skin and eye irritancy or skin
sensitisation potential of the products under evaluation. Owing to the nature of the active substance,
these products should be considered to have the potential to be a respiratory sensitiser.
The FEEDAP Panel concluded that amylase from B. amyloliquefaciens DSM 9553, from
B. amyloliquefaciens NCIMB 30251 (in product B), from A. oryzae CBS 585.94 and from A. oryzae
ATTC SD-5374 and cellulase from Trichoderma longibrachiatum ATCC PTA-100001 have the potential
to improve the characteristics of the silage material prepared from easy, moderate and difﬁcult to
ensile material. The Panel also concluded that the xylanase from T. longibrachiatum CBS 614.94
(product K) has a potential to increase the preservation of easy to ensile material when used in
combination with Pediococcus pentosaceus NCIMB 30238 and Lactobacillus plantarum NCIMB 30237,
with or without product H. The comparison of the results obtained when adding K compared to the
microbial inoculant alone showed an added effect of enzyme K. However, the Panel could not conclude
on the efﬁcacy of the enzyme K when used alone. The Panel could not conclude on the efﬁcacy for
amylase from B. amyloliquefaciens NCIMB 30251 (in product C), cellulase from T. reesei ATCC PTA-
10001 (product G), cellulase from A. niger CBS 120604 (product H), xylanase from T. koningii MUCL
39203 (product J) and glucanase from A. tubingensis MUCL 39199 (product L).
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 10(2)(7) of that Regulation speciﬁes that for
existing products within the meaning of Article 10(1), an application shall be submitted in accordance
with Article 7, within a maximum of seven years after the entry into force of this Regulation.
The European Commission received a request from SILAC EEIG2 for re-evaluation of the authorisation
of the product a-amylase (Enzyme Commission Number (EC) 3.2.1.1) from Aspergillus oryzae, from
Bacillus amyloliquefaciens and Bacillus subtilis, cellulase (EC 3.2.1.4) from Trichoderma longibrachiatum
and Aspergillus niger, b-glucanase (EC 3.2.1.6) from Aspergillus niger and xylanase (EC 3.2.1.8) from
Trichoderma longibrachiatum, when used as a feed additive for all animal species (category:
Technological additives; functional group: silage additives).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under under Article 10(2)
(7) (re-evaluation of an authorised feed additive). EFSA received directly from the applicant the
technical dossier in support of this application. The particulars and documents in support of the
application were considered valid by EFSA as of 26 April 2012.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether the
feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety
for the target animals, consumer, user and the environment and on the efﬁcacy of the product a-amylase,
cellulase, xylanase and b-glucanase, when used under the proposed conditions of use (see Section 3.1.5).
1.2. Additional information
The following enzymes were authorised as silage additives under the provisions of Article 10(1) of
Regulation (EC) No 1831/2003: a-amylase (amylase; Enzyme Commission Number (EC) 3.2.1.1) obtained
from the following strains B. amyloliquefaciens (DSM 9553), B. subtilis (DS098), B. amyloliquefaciens
(SD80), A. oryzae (CBS 585.94) and A. oryzae (DS 114), endo-1,4-b-glucanase (cellulase; EC 3.2.1.4)
from T. longibrachiatum (American type culture collection (ATCC) PTA-10001), T. longibrachiatum (ATCC
74252) and A. niger (CBS 120604 294), endo-1,4-b-xylanase (xylanase; EC 3.2.1.8) from
T. longibrachiatum (MUCL 39203) and T. longibrachiatum (CBS 614.94) and endo1,3(4)-b-glucanase
(glucanase; EC 3.2.1.6) from A. niger (MUCL 39199).1
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier3 in support of the authorisation request for the use of enzyme products as a feed additive. The
technical dossier was prepared following the provisions of Article 7 of Regulation (EC) No 1831/2003,
Regulation (EC) No 429/20084 and the applicable EFSA guidance documents.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the active substances in animal feed. The Executive Summary of the
EURL report can be found in Annex A.5
2.2. Methodologies
The approach followed by the Panel on Additives and Products or Substances used in Animal Feed
(FEEDAP) to assess the safety and the efﬁcacy of the active substances is in line with the principles laid
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 SILAC EEIG, Avenue Louise 120, 1050 Brussels, Belgium.
3 FEED dossier reference: FAD-2010-0367.
4 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
5 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/ﬁnrep_fad-2010-0367_enzyme-group.pdf
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down in Regulation (EC) No 429/2008 and the relevant guidance documents: Guidance on technological
additives (EFSA FEEDAP Panel, 2012a), Technical Guidance for assessing the safety of feed additives for
the environment (EFSA, 2008), Guidance for establishing the safety of additives for the consumer (EFSA
FEEDAP Panel, 2012b), Guidance on studies concerning the safety of use of the additive for users/
workers (EFSA FEEDAP Panel, 2012c), Guidance on the assessment of the toxigenic potential of Bacillus
species used in animal nutrition (EFSA FEEDAP Panel, 2014) and Guidance on the assessment of bacterial
susceptibility to antimicrobials of human and veterinary importance (EFSA FEEDAP Panel, 2012d).
3. Assessment
This opinion deals with the assessment of the safety and efﬁcacy of four enzymes, produced by
fermentation when used as a technological additive, silage additive for all animal species.
3.1. Characterisation6
3.1.1. Characterisation of active substances and production strains
The 11 additives included in this assessment are listed in Table 1 along with the microbial strains
(deﬁned by their accession numbers) from which they are obtained. There are four types of enzymes
a-amylase (amylase; Enzyme Commission Number (EC) 3.2.1.1), endo-1,4-b-glucanase (cellulase; EC
3.2.1.4), endo-1,4-b-xylanase (xylanase; EC 3.2.1.8) and endo1,3(4)-b-glucanase (glucanase; EC
3.2.1.6). Each additive has been given a reference letter which, for convenience, will be used
throughout this Opinion.
The production strain of the amylase contained in product A is a strain of B. amyloliquefaciens
deposited at the Deutsche Sammlung von Mikroorganisms and Zellkulturen (DSMZ) with the accession
number DSM 9553.7 The strain was identiﬁed.8 The absence of toxigenic potential of the strain was
demonstrated following the guidance for the assessment of the toxigenic potential of Bacillus species
used in animal nutrition (EFSA FEEDAP Panel, 2014).9 The susceptibility of the strain to the antibiotics
recommended by EFSA (EFSA FEEDAP Panel, 2012d),10 the strain is considered to be susceptible to all
relevant antibiotics.
The production strain of the amylase contained in product B and C is a strain of
B. amyloliquefaciens deposited at the National Collection of Industrial Food and Marine Bacteria
(NCIMB Ltd) with the accession number 30251 (originally notiﬁed for product B as B. subtilis DS098
and for product C as B. amyloliquefaciens SD80).11 The strain was identiﬁed as B. amyloliquefaciens.12
The absence of toxigenic potential of the strain was demonstrated following the guidance for the
Table 1: The nature and source of the 11 enzymes that are the subject of assessment
Ref letter Enzyme Microbial source
A Amylase Bacillus amyloliquefaciens DSM 9553
B Amylase Bacillus amyloliquefaciens NCIMB 30251
C Amylase Bacillus amyloliquefaciens NCIMB 30251
D Amylase Aspergillus oryzae CBS 585.94
E Amylase Aspergillus oryzae ATTC SD-5374
F Cellulase Trichoderma reesei ATCC PTA-10001
G Cellulase Trichoderma reesei ATCC SD-6331
H Cellulase Aspergillus niger CBS 120604
J Xylanase Trichoderma koningii MUCL 39203
K Xylanase Trichoderma citrinoviride CBS 614.94
L Glucanase Aspergillus tubingensis MUCL 39199
6 This Section has been amended following the provisions of Article 8(6) and Article 18 of Regulation (EC) No 1831/2003.
7 Technical dossier/Section II/Annex II.2.2.1 and Supplementary information February 2015/Annex iib-1.
8 Technical dossier/Supplementary information February 2015/Annex iib-1.
9 Technical dossier/Supplementary information/February 2015/Annex viiia-1.
10 Technical dossier/Supplementary information/May 2017/Annex Q2_MIC determination DSM9553.
11 Technical dossier/Supplementary information May 2017/Annex Q1 and clariﬁcations June 2017.
12 Technical dossier/Supplementary information May 2017/Annex Q1a and Q1b.
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assessment of the toxigenic potential of Bacillus species used in animal nutrition (EFSA FEEDAP Panel,
2014).13 The susceptibility of the strain to the antibiotics recommended by EFSA (EFSA FEEDAP Panel,
2012d)14 showed that the MIC values were below the corresponding cut-off values deﬁned by the
Panel.
With regard to product D, in principle, the production strain should be A. oryzae deposited at the
Centraalbureau voor Schimmelcultures with the deposition number CBS 585.94.15 The applicant
provided the analysis supporting the identiﬁcation and the deposit certiﬁcate for this strain.16 However,
in some passages of the dossier, it is mentioned that the production strain is a derivative of CBS
585.94,17 and the clariﬁcations provided at this regard were not sufﬁcient.18 Therefore, the
Panel cannot conclude on the identity and origin of the production strain of the amylase contained in
product D.
The production strain of the amylase contained in product E is a strain of A. oryzae deposited at
the ATCC with the accession number SD-5374 (formerly deposited at DSMZ as A. oryzae DS 114).19
The strain was identiﬁed as A. oryzae.20
The production strain of the cellulase contained in product F is a strain of Trichoderma reesei21
deposited at the ATCC with the accession number PTA-10001 (originally notiﬁed as T. longibrachiatum
PTA-10001).22 The immediate precursor of the production strain was identiﬁed as Trichoderma reesei.23
The production strain of the cellulase contained in product G was originally T. longibrachiatum ATCC
74252 and now has been changed to T. reesei at the ATCC with the accession number SD 6331.24 The
strain was identiﬁed as T. reesei.25
The production strain of the cellullase contained in product H is a strain of A. niger deposited at the
CBS with the accession number CBS 120604.26 The strain was identiﬁed (and deposited) as A. niger.27
The production strain of the xylanase contained in product J is a strain of Trichoderma koningii that
is deposited at the Culture collection Mycotheque de l’Universite Catholique de Louvain with the
number MUCL 39203 (originally notiﬁed as T. longibrachiatum MUCL 39203).28 The strain was
identiﬁed as T. koningii but since no details were provided on how the analysis was conducted that the
Panel cannot conclude on the identity of this production strain.
The production strain of the xylanase contained in product K is a strain of Trichoderma citrinoviride
(originally notiﬁed as T. longibrachiatum) and is deposited at the CBS with the accession number
614.94.29 The strain was identiﬁed as T. citrinoviride.30
The production strain of the glucanase contained in product L is a strain of Aspergillus tubingensis
that is deposited at the Culture collection Mycotheque de l’Universite Catholique de Louvain with the
number MUCL 39199 (originally notiﬁed as A. niger).31 The strain was identiﬁed as A. tubingensis but
since no details were provided on how the analysis was conducted the Panel cannot conclude on the
identity of this production strain.
13 Technical dossier/Supplementary information February 2015/Annex viiia-2 and 3.
14 Technical dossier/Supplementary information May 2017/Annex Q2.
15 Technical dossier/Supplementary information May 2017/Annex Q1f.
16 Technical dossier/Supplementary information February 2015/Annex ivb2-2 and supplementary information May 2017/Annex Q1f.
17 Technical dossier/Supplementary information February 2015/Annex ii3b and further clariﬁcations June 2017.
18 Technical dossier/Clariﬁcations June 2017.
19 Technical dossier/Supplementary information February 2015 Annex iib-4 and Supplementary information May 2017 Annex Q1c.
20 Technical dossier/Supplementary information February 2015/Annex iib-5a and Supplementary information May 2017/
Annex_Q1c_ATCC Identiﬁcation DS114.
21 Technical dossier/Supplementary information May 2017/Annex Q1d ATCC10001_Mol charact.
22 Technical dossier/Supplementary information May 2017/Annex Q1d_ATCC deposition certiﬁcate.
23 Technical dossier/Supplementary information May 2017/Annex Q1d Identiﬁcation.
24 Technical dossier/Supplementary information February 2015/Annex ib-2, ib-3, iib-6 and iiib.
25 Technical dossier/Supplementary information February 2015/Annex ivb-5.
26 Technical dossier/Section II/Annex 2.2.46 and supplementary information February 2015/Annex iib-7 and Supplementary
information May 2017/Annex Q1e _certiﬁcate of deposition_120604-294.
27 Technical dossier/Section II/Annex 2.2.46.
28 Technical dossier/Section II/Annex II.2.2.9 and Supplementary information February 2015 annex iib-8 and supplementary
information May 2017/Annex Q1d_xylanase_deposition_mucl39203.
29 Technical dossier/Section II/Annex II.2.2.46 and Supplementary information February 2015/Annex iib-7 and Supplementary
information May 2017 Annex Q1e certiﬁcate of deposition_614.94.
30 Technical dossier/Supplementary information February 2018.
31 Technical dossier/Supplementary information May 2017/Annex Q1d glucanase deposition mucl39199.
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3.1.2. Manufacturing process
Details of the production method used for each enzyme were provided together with details of
medium ingredients and processing aids and, in several cases, included HACCP plans.32 Although the
process conditions differ, essentially each enzyme is produced individually by fermentation as a pure
culture in batch, batch fed or continuous culture in sterilised fermentation vessels using sterilised
fermentation ingredients (temperature sterilisation or microﬁltration). After fermentation, the enzyme is
harvested and concentrated using different methodologies. The enzyme preparation is then prepared.
Depending on the process, preservatives and carrier material may be added. The data reported under
the characterisation refers to the enzyme products obtained after this step. In case of product D, the
characterisation was done on the enzyme obtained from strain CBS 585.94. The applicant stated that
no antimicrobials were used during the manufacturing processes.
3.1.3. Characterisation of the additives
The minimum declared content for each enzyme preparation is shown in Table 2. Data on the batch to
batch variation was provided for the different products.33 In general, the minimum declared activity was
conﬁrmed by the analysis of the batches, except in product K. It is noted the high overdosage present in
some of the products, especially products C and D; however, the enzyme activity measured with the
company’s method showed activities in line with the speciﬁcations applied for that method.
Data on the particle size distribution and dusting potential was provided for all products.34 Particle
size distribution (laser diffraction) showed that products A and D do not have respirable particles, the
other products show high amounts of respirable particles, and in all cases, the amount of particles
< 50 lm is higher than 1.5%. The dusting potential was measured using the Stauber Heubach method
and was expressed as g/m3. Results showed in most of the cases a low to moderate dusting potential
(< 0.5 g/m3) with the exception of the xylanase (J and K) products which showed a high-dusting
potential (> 2 g/m3).
The additives are routinely monitored for microbial contamination. Limits are set for coliforms, yeasts
and ﬁlamentous fungi (< 103 colony-forming unit (CFU)/g additive), Escherichia coli (< 10 CFU/g
additive) and Salmonella spp. (absence in 25 g additive). Data from at least three batches of each
product conﬁrmed compliance with these limits for coliforms, Salmonella, E. coli, yeast and ﬁlamentous
fungi.35 For all products, the counts of ﬁlamentous fungi were < 10 CFU/g. These data support the
absence of the production strain for the fungal-derived enzymes. For the bacterial-derived enzymes, the
Table 2: Minimum declared activity and analysed activity of production batches
Ref. Physical form
DNS units/g product
Speciﬁed
A Granule 129,800
B Powder 101,050
C Powder 1,200
D Granule 55,600
E Powder 235,850
F Powder 2,750
G Powder 6,000
H Powder 25,650
J Powder 51,600
K Powder 70,000
L Powder 10,000
DNS: Dinitrosalicylic acid; for details on the deﬁnition see Annex A.
(a): Technical dossier/Section II.
32 Technical dossier/Section II/Annexes 2.31 to 2.3.9 and Supplementary information January 2015/Annex Qiiia.
33 Technical dossier/Section II/Annexes 2.1.6 to 2.1.17 and Supplementary information May 2017/Annex Q7a to c.
34 Technical dossier/Section II/annexes II.2.1.55 to II.2.1.63 and Supplementary information February 2015/Annex iia.
35 Technical dossier/Section II/Annexes II.2.1.18 to II.2.1.41 and Supplementary information February 2015/Annex Qiva and
Supplementary information May 2017/Annexes Q11.
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production strain was not detected for product A and B, but for product C, no data was provided.
However, the manufacturing process should ensure that the strain is not present.36
Speciﬁcations are set for lead (< 5 mg/kg), cadmium (< 0.5 mg/kg), mercury (< 0.5 mg/kg) and
arsenic (< 3 mg/kg). Analysis of at least three batches of each enzyme preparation showed compliance
with these speciﬁcations,37 with the exception for product F for which only lead data were made
available and for C and G for which the limit of detection of arsenic and cadmium was 5 mg/kg.
Speciﬁcations are also set for aﬂatoxin B1 (< 1 lg/kg), data on at least three batches of each
enzyme showing compliance was provided.38 The data provided also included the other mycotoxins.
For the products produced by ﬁlamentous fungi, data on the capacity of the strain to produce
secondary metabolites were provided for the product F, and showed that the strain does not produce
them in laboratory conditions.39 For the rest of the products except product J, the data provided were
on the presence of secondary metabolites in the enzyme products (three batches in each case). In all
the cases, the substances investigated were not detected (limit of detection (LOD) = 50 ng/g enzyme
preparation).
The antimicrobial activity was investigated in the enzyme products in three batches of each enzyme
and was absent.40
3.1.4. Stability
The shelf-life of the enzyme preparations was measured using the in-house method of each
supplier using the sealed, moisture tight packaging in which the additives are normally distributed.41
Storage temperatures variously considered were 5°C (products A, D and F), 10°C (products A, D and
E), 18–25°C (all products, except E) or 40°C (A, C and D). In 8 of 11 cases, only a single batch of the
enzyme was studied. The enzymes had a shelf-life, indicated by high enzyme recovery values, of at
least 6 months at room temperature (range 6–18 months).
Since the application of the enzymes can be through an aqueous suspension/solution, data on the
short-term stability of the enzymes in water was provided for the different enzyme preparations.42 For
products A, B, D, E and F, the stability of the enzymes was tested by preparing suspensions of the
enzyme in water (0.1 mg enzyme/mL). Two subsamples were kept either at 5°C or at 25°C for 48 h.
At 0, 24 and 48 h, the suspensions were homogenised and analysed for enzyme activity. Enzyme
activity losses at 5°C ranged from 0.2% to 8.5% and at 25°C ranged from 1.8% to 20.8%. For
products C, G, J and L, the stability of the enzymes was tested by preparing suspensions in water
(10 mg/mL). Samples were kept at 20–22°C and analysed for enzyme activity at 0, 24 and 48 h,
enzyme activity losses after 48 h were minimal (below 10%). For products H and K, the enzymes were
mixed with water and were kept at 15°C for 72 h. No losses on the enzyme activity were reported.
3.1.5. Conditions of use
The enzymes are intended for use with all forages and for all animal species.43,44 The proposed
enzyme units per kg of fresh matter are provided in Table 3.45
36 Technical dossier/Section II/Annex 2.2.24 and Supplementary information May 2017/Annexes Q11 and Q9 and Q10.
37 Technical dossier/Section II/Annexes II.2.1.42 to 2.1.53 and Supplementary information May 2017 Q9 and Q10.
38 Technical dossier/Section II/Annex 2.1.30 to 2.1.41 and Supplementary information May 2017/Annex Q9.
39 Technical dossier/Supplementary information May 2017/Annex Q3_secondary metabolites.
40 Technical dossier/Section II/Annexes 2.2.24 to 2.2.34, 2.1.31 and 2.1.34 and Supplementary information May 2017 Annex Q8.
41 Technical dossier/Section II/Annexes 2.4.1 to 2.4.10 and Supplementary information May 2017/Annex Q4.
42 Technical dossier/Supplementary information February 2015/Annex Qva.
43 In an expert report it was indicated that product H and K are to be used in easy to ensile substrates. Technical dossier/
Supplementary information May 2017/Annex Q14_Efﬁcacy_Report.
44 According to the applicant the application of these enzymes is done with ‘bacteria directly to silage (granular application) or of
dissolving dried bacterial cells in water with enzymes and spraying onto silage (liquid application)’.
45 Supplementary information May 2017.
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3.2. Safety
3.2.1. Safety for the target species, consumer and environment
The enzymes per se as feed additives are of no concern for the consumers of products derived
from animals receiving such enzymes. Regarding the target species and environment, the
recommended inclusion level of the enzymes under assessment is very low (below 5 mg/kg forage
fresh matter); moreover, the enzymes under assessment occur as normal constituents of silage, and
therefore, the FEEDAP Panel considers that there are no concerns as regards to the active substance
for the target species and the environment.
However, the FEEDAP Panel recognises that this conclusion applies to the active substance, but in
order to extend it to the additive(s), there is the need to consider the presence of other substances
that could be of concern (e.g. toxins produced by the production strain or contaminants).
The production strains for products A, B and C belong to a species (B. amyloliquefaciens) that is
considered by EFSA to be suitable for the Qualiﬁed Presumption of Safety (QPS) approach to safety
assessment (EFSA, 2007; EFSA BIOHAZ Panel, 2017). This approach requires the identity of the strain
to be conclusively established and evidence that the strain does not show resistance to antimicrobials
relevant for humans and animals and the absence of cytotoxic activity. In the view of the FEEDAP
Panel, the identity of the strains has been established and the qualiﬁcations were met, and
consequently, products A, B and C are regarded as safe.
For the products derived from fungal strains, the strains or resulting products46 were tested for the
presence of secondary metabolites which could be of toxicological concern (See Section 3.1.3). These
were found to be below the limits of detection (D, E, G, H, K and L) or the strain was shown not
capable of their production (product F). Taking into account the limits of detection and the inclusion
levels of the enzyme products in the silage, the Panel considers that the products are considered safe.
The Panel notes that, for product D, the conclusion would apply only in the case that the production
strain was A. oryzae CBS 585.94. However, from the data in the dossier, it is not possible to ascertain
that this is the production strain from which the product is actually made.
Finally, the data provided regarding the purity of the products showed values for chemical
contaminants (heavy metals and mycotoxins) that would not be of concern, especially considering the
inclusion level of the products.
Considering all the above, the FEEDAP Panel concludes that the additives under assessment pose
no concerns to the target animals, consumers of food products derived from animals fed the silage
obtained when using these additives or to the environment.
3.2.2. Users
No data were submitted on skin/eye irritation or skin sensitisation. Therefore, no conclusions can
be drawn on the skin and eye irritancy or skin sensitisation potential of the additives under
Table 3: Recommended enzyme activity per kg of fresh matter for the different enzymes
Product DNS enzyme units
(a)/kg
forage fresh matter
A 40.0
B 10.0
C 3.7
D 17.0
E 23.0
F 7.0
G 0.5
H 3.0
J 3.2
K 15.0
L 3.4
(a): DNS dinitrosalicylic acid, for details see Annex A.
46 For product D the analysis were done on the enzyme obtained from A. oryzae CBS 585.94.
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assessment. Given the proteinaceous nature of the active agents, the additives under assessment
should be considered to be potential respiratory sensitisers.
3.3. Efﬁcacy47
The applicant provided in vitro studies in which it was studied the capacity of the enzymes to
release sugars from the non-starch polysaccharides present in different forage substrates. These data/
studies were not considered in the assessment because they did not provide evidence of the efﬁcacy
related to the ensiling process.48,49
The applicant also provided in vitro studies investigating the ensiling capacity of the enzymes under
assessment. Three different protocols were followed.
Considering the effects on dry matter preservation, pH and lactic acid content, the Panel concludes
that the enzyme products amylase from B. amyloliquefaciens DSM 9553 (product A), from
B. amyloliquefaciens NCIMB 30251 (in product B), from A. oryzae CBS 585.94 (product D) and from
A. oryzae ATTC SD-5374 (product E) and cellulase from T. longibrachiatum ATCC PTA-100001 (product
F) have the potential to improve the characteristics of the silage material prepared from easy,
moderate and difﬁcult to ensile material.
The Panel concludes that the xylanase from T. longibrachiatum CBS 614.94 (product K) has a
potential to increase the preservation of easy to ensile material when used in combination with
P. pentosaceus NCIMB 30238 and L. plantarum NCIMB 30237, with or without product H. The
comparison of the results obtained when adding K and the microbial incoulants compared to the
microbial inoculants alone, showed an added effect of the enzyme. However, the Panel cannot
conclude on the efﬁcacy of the enzyme K when used alone.
The Panel cannot conclude on the efﬁcacy for amylase from B. amyloliquefaciens NCIMB 30251 (in
product C), cellulase from T. reesei ATCC PTA-10001 (product G), cellulase from A. niger CBS 120604
(product H), xylanase from T. koningii MUCL 39203 (product J) and glucanase from A. tubingensis MUCL
39199 (product L) because the study designs do not allow a conclusion on the efﬁcacy of these enzymes.
Conclusions
The additives under assessment are considered safe for the target species, consumer of food
products from animals fed treated silage and for the environment. The Panel notes that, for product D,
the conclusion would apply only in the case that the production strain was A. oryzae CBS 585.94.
In the absence of data, no conclusion can be drawn on the skin and eye irritancy of the additive or skin
sensitisation potential of the products under evaluation. Owing to the proteinaceous nature of the active
substances, these products should be considered to have the potential to be a respiratory sensitiser.
Amylase from B. amyloliquefaciens DSM 9553 (product A), from B. amyloliquefaciens NCIMB 30251
(product B), from A. oryzae (product D) and from A. oryzae (ATTC SD-5374 (product E) and cellulase
from T. longibrachiatum ATCC PTA-100001 (product F) have the potential to improve the characteristics
of the silage material prepared from easy, moderate and difﬁcult to ensile material. The xylanase from
T. longibrachiatum CBS 614.94 (product K) has a potential to increase the preservation of easy to ensile
material when used in combination with P. pentosaceus NCIMB 30238 and L. plantarum NCIMB 30237,
with or without product H. The comparison of the results obtained when adding K compared to the
microbial inoculant alone showed an added effect of the enzyme. However, the Panel cannot conclude on
the efﬁcacy of the enzyme K when used alone. The Panel cannot conclude on the efﬁcacy for amylase
from B. amyloliquefaciens NCIMB 30251 (in product C), cellulase from T. reesei ATCC PTA-10001
(product G), cellulase from A. niger CBS 120604 (product H), xylanase from T. koningii MUCL 39203
(product J) and glucanase from A. tubingensis MUCL 39199 (product L).
Documentation provided to EFSA
1) Enzymes as silage additive. November 2010. Submitted by SILAC EEIG.
2) Enzymes as silage additive. Supplementary information. February 2015. Submitted by SILAC
EEIG.
3) Enzymes as silage additive. Supplementary information. May 2017. Submitted by SILAC
EEIG.
47 This Section has been amended following the provisions of Article 8(6) and Article 18 of Regulation (EC) No 1831/2003.
48 Technical dossier/Section IV/Annexes IV.4.1.1 to IV.4.1.5.
49 Technical dossier/Supplementary information February 2015/Annexes viia1 and viia2.
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4) Enzymes as silage additive. Supplementary information. January 2018. Submitted by SILAC
EEIG.
5) Evaluation report of the European Union Reference Laboratory for Feed Additives on the
Methods(s) of Analysis for Enzymes as silage additives.
6) Comments from Member States.
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Method(s) of
Analysis for Enzymes as silage additives
In the current application, authorisation is sought under article 10(2) for Enzymes as silage
additives, under the ‘category’/‘functional groups’ 1(k) ‘technological additives’/‘silage additives’
according to the classiﬁcation system of Annex I of Regulation (EC) No 1831/2003. Speciﬁcally,
authorisation is sought for the use of the feed additives for all animal species.
This group application includes 11 enzymes, which are not intended to be added together in the
silage. They are to be marketed separately in solid forms (granular or powder) containing 10–90%
dextrin compounds (maltodextrin, amylodextrin or dextrin). According to the Applicant, alpha-amylase;
endo-1,4-beta-glucanase; endo-1,3(4)-beta-glucanase and endo-1,4-beta-xylanase are active
substances originating from different microorganisms.
The Applicant expressed the enzyme activities units as follows:
• One alpha-amylase DNS unit is the amount of reducing sugar released as maltose equivalents
in lmol/g per min at pH 4.5 and 37°C from starch under speciﬁed conditions of the assay.
• One beta-glucanase DNS unit is the amount of reducing sugar released as glucose equivalents
in lmol/g per min at pH 4.5 and 37°C from carboxymethyl cellulose (CMC) under speciﬁed
conditions of the assay.
• One xylanase DNS unit is the amount of reducing sugar released as xylose equivalents in lmol/g
per min at pH 4.5 and 37°C from birchwood xylan under speciﬁed conditions of the assay.
Each feed additive is intended to be incorporated into silage either directly in granular form or
spraying a water solution onto silage.
For the quantiﬁcation of the different enzyme activities in the feed additive, the Applicant provided
harmonised single-laboratory validated and further veriﬁed colorimetric methods based on the
quantiﬁcation of coloured compounds produced by dinitrosalicylic acid (DNS). Based on the satisfactory
performance characteristics available, the European Union Reference Laboratory (EURL) recommends
for ofﬁcial control these colorimetric methods for the quantiﬁcation of the enzyme activities in the
individual feed additives.
As the accurate quantiﬁcation of enzymes added to silage is not achievable experimentally, the
EURL cannot evaluate nor recommend any method for ofﬁcial control.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
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